Proteomics International products

The ground-breaking prognostic test that can predict the onset of diabetic kidney disease and future kidney function decline in patients with type 2 diabetes. Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease worldwide1. Most people with diabetic kidney disease do not have symptoms2. Prevention is better than cure - transform clinical outcomes.

Proteomics International has developed a versatile platform technology for discovering diagnostic tests based on the differences in the protein make-up of people with and without a particular disease. By comparing blood or other samples taken from both sick and healthy people, the Company is able to produce a set of “biomarkers”- biological signatures that can be used to test for a particular condition.